Eagle Wealth Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Buy
2,075
+46
+2% +$10.7K 0.2% 51
2026
Q1
$496K Buy
2,029
+9
+0.4% +$2.1K 0.22% 50
2025
Q4
$418K Buy
2,020
+252
+14% +$49.8K 0.19% 59
2025
Q3
$328K Buy
1,768
+152
+9% +$26K 0.16% 65
2025
Q2
$247K Buy
1,616
+5
+0.3% +$769 0.14% 84
2025
Q1
$267K Sell
1,611
-183
-10% -$28.6K 0.16% 71
2024
Q4
$259K Sell
1,794
-500
-22% -$77.5K 0.19% 85
2024
Q3
$372K Buy
2,294
+63
+3% +$10K 0.27% 58
2024
Q2
$326K Buy
2,231
+7
+0.3% +$1.04K 0.26% 60
2024
Q1
$351K Buy
2,224
+6
+0.3% +$955 0.29% 60
2023
Q4
$348K Buy
+2,218
New +$340K 0.21% 60

Other funds holding JNJ

Eagle Wealth Strategies's JNJ Position: Q2 2026 in Review

Eagle Wealth Strategies increased its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, buying an estimated $10.7K and bringing the position to 2,075 shares worth $527K. The position accounts for 0.2% of the portfolio, ranked #51.

Eagle Wealth Strategies first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Eagle Wealth Strategies held 2,075 shares of Johnson & Johnson worth $527K as of Q2 2026.
  • Eagle Wealth Strategies bought 46 Johnson & Johnson shares in Q2 2026, an estimated $10.7K.
  • Johnson & Johnson made up 0.2% of Eagle Wealth Strategies's portfolio in Q2 2026, its #51 holding.
  • Eagle Wealth Strategies first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.